New drug SLV-154 enters human testing for Hard-to-Treat cancers
NCT ID NCT06771219
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This early-phase study tests a new drug called SLV-154 in about 70 people with advanced solid tumors (like head and neck, lung, breast, or ovarian cancer) that have spread. The main goal is to find a safe dose and check for side effects. Researchers will also watch for any signs that the drug is working against the cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Astera Cancer Care
RECRUITINGEast Brunswick, New Jersey, 08816, United States
-
Hoag Memorial Hospital Presbyterian
RECRUITINGNewport Beach, California, 92663, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Mays Cancer Center; University of Texas Health San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Northwest Medical Specialties, PLLC
RECRUITINGTacoma, Washington, 98405, United States
-
Oncology Consultants
RECRUITINGHouston, Texas, 77030, United States
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
-
University of Washington / Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
-
Washington University
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genetic test may spare patients from unnecessary thyroid surgery
- Can your own immune cells beat advanced cancer?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a pill keep lung cancer from returning after surgery?
- What raises endometrial cancer risk in black women? a study digs in
- A lifeline for cancer caregivers: can simple phone support reduce their stress?